Leuko

Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management ot the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws, and laboratory infrastructure.

—

Learn more at: leuko.com